abm drug discovery
hsa-miR-186 Stable HaCaT Cell Line | T6462
- SKU:
- T6462
- Availability:
- 5 to 7 Days Shipment
Description
abm | hsa-miR-186 Stable HaCaT Cell Line | T6462
HaCaT cells were transfected with pEP-hsa-miR-186 vector, and stable cells were selected for under puromycin selection pressure to establish the hsa-miR-186 Stable HaCaT Cell Line. hsa-miR-186 is a miRNA sequence which is 22 nucleotides long. Some studies have indicated that the miRNA sequence may have a role in cancer, and may have various expression levels in tissues dependent on the cancer type. This cell line is value in studies on its role in cancer biology.
Biosafety:
II
Organism:
Human (H. sapiens)
Source Organ:
Skin
Growth Properties:
Adherent
Morphology:
Epithelial-like
Clones:
N/A
Passage Number:
N/A
Population Doner:
N/A
Seeding Density:
N/A
Markers:
hsa-miR-186 Puromycin-resistant
Applications:
For Research Use Only
Doner Gender:
Male
Donor Ethnicity:
N/A
Knockdown Method:
N/A
Induction:
N/A
Overexpression:
N/A
Freeze Thaw:
N/A
Propagation:
Preservation:
1. Freeze Medium: 90% FBS and 10% DMSO.
2. Storage Temperature: Liquid nitrogen vapour phase.
Quality Control:
1) Puromycin selection
Tumorgenicn:
N/A
Shipping Conditions:
Dry Ice
Storage Contidions:
-180°C